Brain Tumor Researchers and Industry Experts Join Forces to Bring Emerging Therapies from Lab to Patients with Brain Tumors

NEW YORK,  NY – More than 22,000 people in the United States are diagnosed with brain or spinal tumors each year and more than 13,000 patients die each year from the malignant tumors, according to the American Cancer Society.

That’s why many of the nation’s top cancer specialists and biotech industry experts came together on Friday May 29th for Lenox Hill Hospital’s first Brian Tumor Biotech Summit.  The event brought together innovators in neuroscience and oncology with investors to promote innovative new therapies for patients with brain tumors.

"The purpose of this conference was to bridge the gap between basic and clinical science," said Dr. John Boockvar, Director of the Brain Tumor Center at Lenox Hill Hospital and Co-Director of  The Brain Tumor Biotech Center at North Shore-LIJ’s Feinstein Institute for Medical Research.  “Our goal is to foster and encourage collaboration among our neuroscience colleagues in order to accelerate the development of new, life-saving therapies for patients with brain tumors.”

Industry leaders from the biotech industry, venture capital firms, finance, non-profit foundations and pharmaceutical companies participated in discussions regarding ways to get new research findings noticed and funded.   Top brain tumor researchers from across the country presented their latest advances in vaccine treatments, nanotechnology, stem cell biology, angiogenesis, gene therapy, targeted therapeutics, novel medical devices in the hopes of sparking interest and generating funding to bring these ideas from bench to bedside.

"Brain cancer touches the lives of thousands of families a year, and it is vital that we develop novel treatments and therapeutics that will better target malignant tumors and enhance patient care," said Dr. Boockvar.  "Since federal funding for research has plummeted it has become more important than ever for brain tumor researchers to supplement their government grants with private funding to advance their research."

"Because of this Biotech Summit, each day we continue to work together in the fight against brain cancer to ultimately find a cure, and we get closer to making brain cancer a chronic disease with great quality of life,” said Mario Lichtenstein, Founder of Voices Against Brain Cancer and co-sponsor of the summit.

To learn more about LHH Brain Tumor Center visit:

To learn more about North Shore- LIJ’s Feinstein Institute for Medical Research’s  Brain Tumor Biotech Center visit:

Focus onHealth TV

Watch Focus onHealth, Northwell Health's TV show. It's the healthy way to stay informed!